SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 488 filers reported holding SEAGEN INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,556,777,702 | +10.3% | 12,051,745 | +0.1% | 0.07% | +15.6% |
| Q2 2023 | $2,317,568,486 | +2.3% | 12,041,819 | +7.6% | 0.06% | -4.5% |
| Q1 2023 | $2,265,866,470 | +48.6% | 11,191,122 | -5.7% | 0.07% | +39.6% |
| Q4 2022 | $1,524,389,990 | -5.8% | 11,862,034 | +0.3% | 0.05% | -12.7% |
| Q3 2022 | $1,618,264,000 | -20.0% | 11,826,822 | +3.5% | 0.06% | -15.4% |
| Q2 2022 | $2,022,825,000 | +2.5% | 11,432,260 | -16.6% | 0.06% | +22.6% |
| Q1 2022 | $1,974,113,000 | -4.3% | 13,704,355 | +2.7% | 0.05% | 0.0% |
| Q4 2021 | $2,062,637,000 | -0.8% | 13,341,753 | +8.9% | 0.05% | -8.6% |
| Q3 2021 | $2,080,190,000 | +9.6% | 12,250,826 | +1.9% | 0.06% | +9.4% |
| Q2 2021 | $1,898,179,000 | +8.8% | 12,022,916 | -4.4% | 0.05% | +3.9% |
| Q1 2021 | $1,745,448,000 | -20.4% | 12,569,833 | +0.4% | 0.05% | -27.1% |
| Q4 2020 | $2,192,768,000 | – | 12,520,079 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |